BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35835092)

  • 1. Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study.
    García Vicente AM; Amo-Salas M; Sandoval Valencia H; Lozano Setien E; Soriano Castrejón ÁM
    Clin Nucl Med; 2022 Oct; 47(10):856-862. PubMed ID: 35835092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria.
    García Vicente AM; Pena Pardo FJ; Amo-Salas M; Villena Martín M; López Menéndez C; Soriano Castrejón ÁM; Pérez-Beteta J
    Clin Nucl Med; 2022 Jun; 47(6):480-487. PubMed ID: 35426853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy.
    Karahissarlian V; Sargos P; Blais E; Cazeau AL; Fontes F; Petitpierre F; Rigou G; De Vaugelade C; Mariey A; Hindié E; Thomas L
    Cancer Radiother; 2020 Jul; 24(4):323-331. PubMed ID: 32532578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility.
    Gómez-Río M; Testart Dardel N; Santiago Chinchilla A; Rodríguez-Fernández A; Olivares Granados G; Luque Caro R; Zurita Herrera M; Chamorro Santos CE; Lardelli-Claret P; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):886-95. PubMed ID: 25673054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PET-CT with
    Puche-Sanz I; Triviño-Ibáñez E; Vázquez-Alonso F; Llamas-Elvira JM; Cózar-Olmo JM; Rodríguez-Fernández A
    Actas Urol Esp; 2017 Sep; 41(7):437-444. PubMed ID: 28389027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.
    Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III Study of
    Olivier P; Giraudet AL; Skanjeti A; Merlin C; Weinmann P; Rudolph I; Hoepping A; Gauthé M
    J Nucl Med; 2023 Apr; 64(4):579-585. PubMed ID: 36418170
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Ferrari C; Mammucci P; Lavelli V; Pisani AR; Nappi AG; Rubini D; Sardaro A; Rubini G
    Tomography; 2022 Nov; 8(6):2709-2722. PubMed ID: 36412685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of Cervical Ultrasound,
    Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
    J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan.
    Tong AK; Zhang ZX; Zaheer S; Yan XS
    Clin Imaging; 2016; 40(3):486-91. PubMed ID: 27133692
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kanoun S; Walker P; Vrigneaud JM; Depardon E; Barbier V; Humbert O; Moulin M; Créhange G; Cormier L; Loffroy R; Brunotte F; Cochet A
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):986-994. PubMed ID: 28333020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.
    Simone G; Di Pierro GB; Papalia R; Sciuto R; Rea S; Ferriero M; Guaglianone S; Maini CL; Gallucci M
    World J Urol; 2015 Oct; 33(10):1511-8. PubMed ID: 25577130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
    Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of [
    Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
    Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of
    Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
    Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Grkovski M; Kohutek ZA; Schöder H; Brennan CW; Tabar VS; Gutin PH; Zhang Z; Young RJ; Beattie BJ; Zanzonico PB; Huse JT; Rosenblum MK; Blasberg RG; Humm JL; Beal K
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1446-1457. PubMed ID: 31865407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of
    Gauthé M; Belissant O; Girard A; Zhang Yin J; Ohnona J; Cottereau AS; Nataf V; Balogova S; Pontvert D; Lebret T; Guillonneau B; Cussenot O; Talbot JN
    Prog Urol; 2017; 27(8-9):474-481. PubMed ID: 28576423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.